Skip to content
Tech News
clear
Topics: Today This Week This Month This Year
1.
Gilead Sciences Swings to Loss on R&D Costs as HIV-Drug Sales Lift Revenue (feeds.content.dowjones.io)
2.
Cramer's lightning round: Nokia still has room to run (cnbc.com)
3.
Gilead Sciences to Buy Clinical-Stage Biotech Tubulis for Up to $5 Billion (feeds.content.dowjones.io)
4.
Gilead Sciences to Buy Ouro Medicines, Collaborate With Galapagos on Purchased Assets (feeds.content.dowjones.io)
5.
Gilead Sciences to Buy Ouro Medicines for Up to $2.18 Billion (feeds.content.dowjones.io)
Today's top topics: apple google openai anthropic android spacex amazon microsoft samsung android authority
View all today's topics →